nodes	percent_of_prediction	percent_of_DWPC	metapath
Propafenone—Dextropropoxyphene—Tamoxifen—pancreatic cancer	0.122	0.299	CrCrCtD
Propafenone—Phenoxybenzamine—Tamoxifen—pancreatic cancer	0.122	0.299	CrCrCtD
Propafenone—Benzphetamine—Tamoxifen—pancreatic cancer	0.0853	0.209	CrCrCtD
Propafenone—Benzyl Benzoate—Tamoxifen—pancreatic cancer	0.079	0.194	CrCrCtD
Propafenone—KCNH2—Sunitinib—pancreatic cancer	0.0421	0.102	CbGbCtD
Propafenone—CYP2C8—Tamoxifen—pancreatic cancer	0.0277	0.0674	CbGbCtD
Propafenone—CYP1A2—Dacarbazine—pancreatic cancer	0.027	0.0656	CbGbCtD
Propafenone—CYP2C8—Erlotinib—pancreatic cancer	0.0236	0.0573	CbGbCtD
Propafenone—CYP1A2—Tamoxifen—pancreatic cancer	0.0215	0.0522	CbGbCtD
Propafenone—CYP2C8—Fluorouracil—pancreatic cancer	0.0204	0.0497	CbGbCtD
Propafenone—CYP2C9—Tamoxifen—pancreatic cancer	0.0193	0.047	CbGbCtD
Propafenone—ABCB1—Tamoxifen—pancreatic cancer	0.0188	0.0456	CbGbCtD
Propafenone—CYP1A2—Erlotinib—pancreatic cancer	0.0182	0.0444	CbGbCtD
Propafenone—CYP2D6—Tamoxifen—pancreatic cancer	0.0177	0.043	CbGbCtD
Propafenone—ABCB1—Gemcitabine—pancreatic cancer	0.0162	0.0393	CbGbCtD
Propafenone—ABCB1—Erlotinib—pancreatic cancer	0.0159	0.0388	CbGbCtD
Propafenone—CYP1A2—Fluorouracil—pancreatic cancer	0.0158	0.0385	CbGbCtD
Propafenone—CYP2D6—Erlotinib—pancreatic cancer	0.015	0.0366	CbGbCtD
Propafenone—ABCB1—Irinotecan—pancreatic cancer	0.0144	0.0351	CbGbCtD
Propafenone—CYP2C9—Fluorouracil—pancreatic cancer	0.0142	0.0347	CbGbCtD
Propafenone—CYP3A4—Tamoxifen—pancreatic cancer	0.0112	0.0274	CbGbCtD
Propafenone—ABCB1—Docetaxel—pancreatic cancer	0.0106	0.0257	CbGbCtD
Propafenone—ABCB1—Sunitinib—pancreatic cancer	0.0105	0.0256	CbGbCtD
Propafenone—CYP3A4—Erlotinib—pancreatic cancer	0.00956	0.0233	CbGbCtD
Propafenone—CYP3A4—Irinotecan—pancreatic cancer	0.00863	0.021	CbGbCtD
Propafenone—ABCB1—Doxorubicin—pancreatic cancer	0.00787	0.0191	CbGbCtD
Propafenone—CYP2D6—Doxorubicin—pancreatic cancer	0.00741	0.018	CbGbCtD
Propafenone—CYP3A4—Docetaxel—pancreatic cancer	0.00632	0.0154	CbGbCtD
Propafenone—CYP3A4—Sunitinib—pancreatic cancer	0.0063	0.0153	CbGbCtD
Propafenone—CYP3A4—Doxorubicin—pancreatic cancer	0.00471	0.0115	CbGbCtD
Propafenone—Carvedilol—HIF1A—pancreatic cancer	0.00125	0.544	CrCbGaD
Propafenone—Carvedilol—VEGFA—pancreatic cancer	0.000505	0.219	CrCbGaD
Propafenone—Salsalate—PTGS2—pancreatic cancer	0.000274	0.119	CrCbGaD
Propafenone—Oxaprozin—PTGS2—pancreatic cancer	0.000274	0.119	CrCbGaD
Propafenone—Asthenia—Irinotecan—pancreatic cancer	8.06e-05	0.000451	CcSEcCtD
Propafenone—Neuropathy peripheral—Epirubicin—pancreatic cancer	8.05e-05	0.00045	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	8.04e-05	0.00045	CcSEcCtD
Propafenone—Jaundice—Epirubicin—pancreatic cancer	8e-05	0.000448	CcSEcCtD
Propafenone—Stomatitis—Epirubicin—pancreatic cancer	8e-05	0.000448	CcSEcCtD
Propafenone—Dysuria—Doxorubicin—pancreatic cancer	7.97e-05	0.000446	CcSEcCtD
Propafenone—Hypersensitivity—Fluorouracil—pancreatic cancer	7.92e-05	0.000443	CcSEcCtD
Propafenone—Dry mouth—Docetaxel—pancreatic cancer	7.92e-05	0.000443	CcSEcCtD
Propafenone—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	7.92e-05	0.000443	CcSEcCtD
Propafenone—Pollakiuria—Doxorubicin—pancreatic cancer	7.87e-05	0.00044	CcSEcCtD
Propafenone—Asthenia—Gemcitabine—pancreatic cancer	7.85e-05	0.000439	CcSEcCtD
Propafenone—Haematuria—Epirubicin—pancreatic cancer	7.83e-05	0.000438	CcSEcCtD
Propafenone—Confusional state—Docetaxel—pancreatic cancer	7.83e-05	0.000438	CcSEcCtD
Propafenone—Hepatobiliary disease—Epirubicin—pancreatic cancer	7.76e-05	0.000434	CcSEcCtD
Propafenone—Oedema—Docetaxel—pancreatic cancer	7.76e-05	0.000434	CcSEcCtD
Propafenone—Weight increased—Doxorubicin—pancreatic cancer	7.75e-05	0.000434	CcSEcCtD
Propafenone—Epistaxis—Epirubicin—pancreatic cancer	7.74e-05	0.000433	CcSEcCtD
Propafenone—Pruritus—Gemcitabine—pancreatic cancer	7.74e-05	0.000433	CcSEcCtD
Propafenone—Infection—Docetaxel—pancreatic cancer	7.71e-05	0.000431	CcSEcCtD
Propafenone—Weight decreased—Doxorubicin—pancreatic cancer	7.71e-05	0.000431	CcSEcCtD
Propafenone—Hyperglycaemia—Doxorubicin—pancreatic cancer	7.68e-05	0.00043	CcSEcCtD
Propafenone—Diarrhoea—Irinotecan—pancreatic cancer	7.68e-05	0.00043	CcSEcCtD
Propafenone—Agranulocytosis—Epirubicin—pancreatic cancer	7.66e-05	0.000428	CcSEcCtD
Propafenone—Shock—Docetaxel—pancreatic cancer	7.64e-05	0.000427	CcSEcCtD
Propafenone—Nervous system disorder—Docetaxel—pancreatic cancer	7.61e-05	0.000426	CcSEcCtD
Propafenone—Pruritus—Fluorouracil—pancreatic cancer	7.61e-05	0.000426	CcSEcCtD
Propafenone—Thrombocytopenia—Docetaxel—pancreatic cancer	7.6e-05	0.000425	CcSEcCtD
Propafenone—Infestation—Doxorubicin—pancreatic cancer	7.6e-05	0.000425	CcSEcCtD
Propafenone—Infestation NOS—Doxorubicin—pancreatic cancer	7.6e-05	0.000425	CcSEcCtD
Propafenone—Drowsiness—Doxorubicin—pancreatic cancer	7.6e-05	0.000425	CcSEcCtD
Propafenone—Tachycardia—Docetaxel—pancreatic cancer	7.58e-05	0.000424	CcSEcCtD
Propafenone—Skin disorder—Docetaxel—pancreatic cancer	7.54e-05	0.000422	CcSEcCtD
Propafenone—Bradycardia—Epirubicin—pancreatic cancer	7.5e-05	0.00042	CcSEcCtD
Propafenone—Diarrhoea—Gemcitabine—pancreatic cancer	7.48e-05	0.000419	CcSEcCtD
Propafenone—Renal failure—Doxorubicin—pancreatic cancer	7.47e-05	0.000418	CcSEcCtD
Propafenone—Neuropathy peripheral—Doxorubicin—pancreatic cancer	7.45e-05	0.000416	CcSEcCtD
Propafenone—Dizziness—Irinotecan—pancreatic cancer	7.43e-05	0.000415	CcSEcCtD
Propafenone—Haemoglobin—Epirubicin—pancreatic cancer	7.41e-05	0.000414	CcSEcCtD
Propafenone—Stomatitis—Doxorubicin—pancreatic cancer	7.4e-05	0.000414	CcSEcCtD
Propafenone—Jaundice—Doxorubicin—pancreatic cancer	7.4e-05	0.000414	CcSEcCtD
Propafenone—Anorexia—Docetaxel—pancreatic cancer	7.4e-05	0.000414	CcSEcCtD
Propafenone—Rhinitis—Epirubicin—pancreatic cancer	7.39e-05	0.000413	CcSEcCtD
Propafenone—Hepatitis—Epirubicin—pancreatic cancer	7.37e-05	0.000412	CcSEcCtD
Propafenone—Haemorrhage—Epirubicin—pancreatic cancer	7.37e-05	0.000412	CcSEcCtD
Propafenone—Diarrhoea—Fluorouracil—pancreatic cancer	7.36e-05	0.000412	CcSEcCtD
Propafenone—Hypoaesthesia—Epirubicin—pancreatic cancer	7.33e-05	0.00041	CcSEcCtD
Propafenone—Urinary tract disorder—Epirubicin—pancreatic cancer	7.28e-05	0.000407	CcSEcCtD
Propafenone—Hypotension—Docetaxel—pancreatic cancer	7.25e-05	0.000406	CcSEcCtD
Propafenone—Haematuria—Doxorubicin—pancreatic cancer	7.24e-05	0.000405	CcSEcCtD
Propafenone—Connective tissue disorder—Epirubicin—pancreatic cancer	7.24e-05	0.000405	CcSEcCtD
Propafenone—Urethral disorder—Epirubicin—pancreatic cancer	7.22e-05	0.000404	CcSEcCtD
Propafenone—Hepatobiliary disease—Doxorubicin—pancreatic cancer	7.18e-05	0.000402	CcSEcCtD
Propafenone—Epistaxis—Doxorubicin—pancreatic cancer	7.16e-05	0.000401	CcSEcCtD
Propafenone—Vomiting—Irinotecan—pancreatic cancer	7.14e-05	0.000399	CcSEcCtD
Propafenone—Dizziness—Fluorouracil—pancreatic cancer	7.11e-05	0.000398	CcSEcCtD
Propafenone—Visual impairment—Epirubicin—pancreatic cancer	7.1e-05	0.000397	CcSEcCtD
Propafenone—Agranulocytosis—Doxorubicin—pancreatic cancer	7.09e-05	0.000396	CcSEcCtD
Propafenone—Rash—Irinotecan—pancreatic cancer	7.08e-05	0.000396	CcSEcCtD
Propafenone—Dermatitis—Irinotecan—pancreatic cancer	7.07e-05	0.000396	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	7.07e-05	0.000396	CcSEcCtD
Propafenone—Headache—Irinotecan—pancreatic cancer	7.03e-05	0.000393	CcSEcCtD
Propafenone—Insomnia—Docetaxel—pancreatic cancer	7.02e-05	0.000393	CcSEcCtD
Propafenone—Paraesthesia—Docetaxel—pancreatic cancer	6.97e-05	0.00039	CcSEcCtD
Propafenone—Vomiting—Gemcitabine—pancreatic cancer	6.95e-05	0.000389	CcSEcCtD
Propafenone—Bradycardia—Doxorubicin—pancreatic cancer	6.94e-05	0.000388	CcSEcCtD
Propafenone—Dyspnoea—Docetaxel—pancreatic cancer	6.92e-05	0.000387	CcSEcCtD
Propafenone—Somnolence—Docetaxel—pancreatic cancer	6.9e-05	0.000386	CcSEcCtD
Propafenone—Rash—Gemcitabine—pancreatic cancer	6.9e-05	0.000386	CcSEcCtD
Propafenone—Dermatitis—Gemcitabine—pancreatic cancer	6.89e-05	0.000385	CcSEcCtD
Propafenone—Eye disorder—Epirubicin—pancreatic cancer	6.89e-05	0.000385	CcSEcCtD
Propafenone—Tinnitus—Epirubicin—pancreatic cancer	6.87e-05	0.000384	CcSEcCtD
Propafenone—Haemoglobin—Doxorubicin—pancreatic cancer	6.85e-05	0.000383	CcSEcCtD
Propafenone—Headache—Gemcitabine—pancreatic cancer	6.85e-05	0.000383	CcSEcCtD
Propafenone—Flushing—Epirubicin—pancreatic cancer	6.84e-05	0.000383	CcSEcCtD
Propafenone—Cardiac disorder—Epirubicin—pancreatic cancer	6.84e-05	0.000383	CcSEcCtD
Propafenone—Vomiting—Fluorouracil—pancreatic cancer	6.84e-05	0.000382	CcSEcCtD
Propafenone—Rhinitis—Doxorubicin—pancreatic cancer	6.84e-05	0.000382	CcSEcCtD
Propafenone—Dyspepsia—Docetaxel—pancreatic cancer	6.83e-05	0.000382	CcSEcCtD
Propafenone—Haemorrhage—Doxorubicin—pancreatic cancer	6.82e-05	0.000381	CcSEcCtD
Propafenone—Hepatitis—Doxorubicin—pancreatic cancer	6.82e-05	0.000381	CcSEcCtD
Propafenone—Hypoaesthesia—Doxorubicin—pancreatic cancer	6.78e-05	0.000379	CcSEcCtD
Propafenone—Rash—Fluorouracil—pancreatic cancer	6.78e-05	0.000379	CcSEcCtD
Propafenone—Dermatitis—Fluorouracil—pancreatic cancer	6.77e-05	0.000379	CcSEcCtD
Propafenone—Decreased appetite—Docetaxel—pancreatic cancer	6.75e-05	0.000377	CcSEcCtD
Propafenone—Headache—Fluorouracil—pancreatic cancer	6.74e-05	0.000377	CcSEcCtD
Propafenone—Urinary tract disorder—Doxorubicin—pancreatic cancer	6.73e-05	0.000377	CcSEcCtD
Propafenone—Gastrointestinal disorder—Docetaxel—pancreatic cancer	6.7e-05	0.000375	CcSEcCtD
Propafenone—Connective tissue disorder—Doxorubicin—pancreatic cancer	6.7e-05	0.000375	CcSEcCtD
Propafenone—Fatigue—Docetaxel—pancreatic cancer	6.69e-05	0.000374	CcSEcCtD
Propafenone—Angiopathy—Epirubicin—pancreatic cancer	6.69e-05	0.000374	CcSEcCtD
Propafenone—Urethral disorder—Doxorubicin—pancreatic cancer	6.68e-05	0.000374	CcSEcCtD
Propafenone—Nausea—Irinotecan—pancreatic cancer	6.67e-05	0.000373	CcSEcCtD
Propafenone—Immune system disorder—Epirubicin—pancreatic cancer	6.66e-05	0.000372	CcSEcCtD
Propafenone—Mediastinal disorder—Epirubicin—pancreatic cancer	6.64e-05	0.000371	CcSEcCtD
Propafenone—Constipation—Docetaxel—pancreatic cancer	6.64e-05	0.000371	CcSEcCtD
Propafenone—Pain—Docetaxel—pancreatic cancer	6.64e-05	0.000371	CcSEcCtD
Propafenone—Arrhythmia—Epirubicin—pancreatic cancer	6.58e-05	0.000368	CcSEcCtD
Propafenone—Visual impairment—Doxorubicin—pancreatic cancer	6.57e-05	0.000368	CcSEcCtD
Propafenone—Alopecia—Epirubicin—pancreatic cancer	6.51e-05	0.000364	CcSEcCtD
Propafenone—Nausea—Gemcitabine—pancreatic cancer	6.5e-05	0.000363	CcSEcCtD
Propafenone—Mental disorder—Epirubicin—pancreatic cancer	6.46e-05	0.000361	CcSEcCtD
Propafenone—Malnutrition—Epirubicin—pancreatic cancer	6.42e-05	0.000359	CcSEcCtD
Propafenone—Erythema—Epirubicin—pancreatic cancer	6.42e-05	0.000359	CcSEcCtD
Propafenone—Feeling abnormal—Docetaxel—pancreatic cancer	6.4e-05	0.000358	CcSEcCtD
Propafenone—Nausea—Fluorouracil—pancreatic cancer	6.39e-05	0.000357	CcSEcCtD
Propafenone—Eye disorder—Doxorubicin—pancreatic cancer	6.37e-05	0.000356	CcSEcCtD
Propafenone—Tinnitus—Doxorubicin—pancreatic cancer	6.36e-05	0.000356	CcSEcCtD
Propafenone—Gastrointestinal pain—Docetaxel—pancreatic cancer	6.35e-05	0.000355	CcSEcCtD
Propafenone—Flushing—Doxorubicin—pancreatic cancer	6.33e-05	0.000354	CcSEcCtD
Propafenone—Cardiac disorder—Doxorubicin—pancreatic cancer	6.33e-05	0.000354	CcSEcCtD
Propafenone—Flatulence—Epirubicin—pancreatic cancer	6.32e-05	0.000354	CcSEcCtD
Propafenone—Tension—Epirubicin—pancreatic cancer	6.3e-05	0.000352	CcSEcCtD
Propafenone—Dysgeusia—Epirubicin—pancreatic cancer	6.28e-05	0.000351	CcSEcCtD
Propafenone—Nervousness—Epirubicin—pancreatic cancer	6.23e-05	0.000348	CcSEcCtD
Propafenone—Angiopathy—Doxorubicin—pancreatic cancer	6.19e-05	0.000346	CcSEcCtD
Propafenone—Muscle spasms—Epirubicin—pancreatic cancer	6.17e-05	0.000345	CcSEcCtD
Propafenone—Immune system disorder—Doxorubicin—pancreatic cancer	6.16e-05	0.000344	CcSEcCtD
Propafenone—Mediastinal disorder—Doxorubicin—pancreatic cancer	6.15e-05	0.000344	CcSEcCtD
Propafenone—Body temperature increased—Docetaxel—pancreatic cancer	6.14e-05	0.000343	CcSEcCtD
Propafenone—Abdominal pain—Docetaxel—pancreatic cancer	6.14e-05	0.000343	CcSEcCtD
Propafenone—Arrhythmia—Doxorubicin—pancreatic cancer	6.09e-05	0.000341	CcSEcCtD
Propafenone—Vision blurred—Epirubicin—pancreatic cancer	6.05e-05	0.000338	CcSEcCtD
Propafenone—Alopecia—Doxorubicin—pancreatic cancer	6.03e-05	0.000337	CcSEcCtD
Propafenone—Mental disorder—Doxorubicin—pancreatic cancer	5.97e-05	0.000334	CcSEcCtD
Propafenone—Ill-defined disorder—Epirubicin—pancreatic cancer	5.95e-05	0.000333	CcSEcCtD
Propafenone—Erythema—Doxorubicin—pancreatic cancer	5.94e-05	0.000332	CcSEcCtD
Propafenone—Malnutrition—Doxorubicin—pancreatic cancer	5.94e-05	0.000332	CcSEcCtD
Propafenone—Anaemia—Epirubicin—pancreatic cancer	5.93e-05	0.000332	CcSEcCtD
Propafenone—Flatulence—Doxorubicin—pancreatic cancer	5.85e-05	0.000327	CcSEcCtD
Propafenone—Tension—Doxorubicin—pancreatic cancer	5.82e-05	0.000326	CcSEcCtD
Propafenone—Dysgeusia—Doxorubicin—pancreatic cancer	5.81e-05	0.000325	CcSEcCtD
Propafenone—Malaise—Epirubicin—pancreatic cancer	5.79e-05	0.000324	CcSEcCtD
Propafenone—Nervousness—Doxorubicin—pancreatic cancer	5.77e-05	0.000322	CcSEcCtD
Propafenone—Vertigo—Epirubicin—pancreatic cancer	5.76e-05	0.000322	CcSEcCtD
Propafenone—Syncope—Epirubicin—pancreatic cancer	5.75e-05	0.000322	CcSEcCtD
Propafenone—Leukopenia—Epirubicin—pancreatic cancer	5.74e-05	0.000321	CcSEcCtD
Propafenone—Hypersensitivity—Docetaxel—pancreatic cancer	5.72e-05	0.00032	CcSEcCtD
Propafenone—Muscle spasms—Doxorubicin—pancreatic cancer	5.71e-05	0.000319	CcSEcCtD
Propafenone—Palpitations—Epirubicin—pancreatic cancer	5.67e-05	0.000317	CcSEcCtD
Propafenone—Loss of consciousness—Epirubicin—pancreatic cancer	5.64e-05	0.000315	CcSEcCtD
Propafenone—Cough—Epirubicin—pancreatic cancer	5.6e-05	0.000313	CcSEcCtD
Propafenone—Vision blurred—Doxorubicin—pancreatic cancer	5.59e-05	0.000313	CcSEcCtD
Propafenone—Asthenia—Docetaxel—pancreatic cancer	5.57e-05	0.000311	CcSEcCtD
Propafenone—Convulsion—Epirubicin—pancreatic cancer	5.56e-05	0.000311	CcSEcCtD
Propafenone—Hypertension—Epirubicin—pancreatic cancer	5.54e-05	0.00031	CcSEcCtD
Propafenone—Ill-defined disorder—Doxorubicin—pancreatic cancer	5.51e-05	0.000308	CcSEcCtD
Propafenone—Pruritus—Docetaxel—pancreatic cancer	5.49e-05	0.000307	CcSEcCtD
Propafenone—Anaemia—Doxorubicin—pancreatic cancer	5.49e-05	0.000307	CcSEcCtD
Propafenone—Chest pain—Epirubicin—pancreatic cancer	5.46e-05	0.000305	CcSEcCtD
Propafenone—Myalgia—Epirubicin—pancreatic cancer	5.46e-05	0.000305	CcSEcCtD
Propafenone—Anxiety—Epirubicin—pancreatic cancer	5.44e-05	0.000304	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	5.42e-05	0.000303	CcSEcCtD
Propafenone—Discomfort—Epirubicin—pancreatic cancer	5.4e-05	0.000302	CcSEcCtD
Propafenone—Malaise—Doxorubicin—pancreatic cancer	5.35e-05	0.000299	CcSEcCtD
Propafenone—Dry mouth—Epirubicin—pancreatic cancer	5.34e-05	0.000299	CcSEcCtD
Propafenone—Vertigo—Doxorubicin—pancreatic cancer	5.33e-05	0.000298	CcSEcCtD
Propafenone—Syncope—Doxorubicin—pancreatic cancer	5.32e-05	0.000298	CcSEcCtD
Propafenone—Leukopenia—Doxorubicin—pancreatic cancer	5.31e-05	0.000297	CcSEcCtD
Propafenone—Diarrhoea—Docetaxel—pancreatic cancer	5.31e-05	0.000297	CcSEcCtD
Propafenone—Confusional state—Epirubicin—pancreatic cancer	5.28e-05	0.000295	CcSEcCtD
Propafenone—Palpitations—Doxorubicin—pancreatic cancer	5.25e-05	0.000293	CcSEcCtD
Propafenone—Oedema—Epirubicin—pancreatic cancer	5.24e-05	0.000293	CcSEcCtD
Propafenone—Loss of consciousness—Doxorubicin—pancreatic cancer	5.22e-05	0.000292	CcSEcCtD
Propafenone—Infection—Epirubicin—pancreatic cancer	5.2e-05	0.000291	CcSEcCtD
Propafenone—Cough—Doxorubicin—pancreatic cancer	5.18e-05	0.00029	CcSEcCtD
Propafenone—Shock—Epirubicin—pancreatic cancer	5.15e-05	0.000288	CcSEcCtD
Propafenone—Convulsion—Doxorubicin—pancreatic cancer	5.14e-05	0.000288	CcSEcCtD
Propafenone—Nervous system disorder—Epirubicin—pancreatic cancer	5.13e-05	0.000287	CcSEcCtD
Propafenone—Dizziness—Docetaxel—pancreatic cancer	5.13e-05	0.000287	CcSEcCtD
Propafenone—Thrombocytopenia—Epirubicin—pancreatic cancer	5.13e-05	0.000287	CcSEcCtD
Propafenone—Hypertension—Doxorubicin—pancreatic cancer	5.12e-05	0.000287	CcSEcCtD
Propafenone—Tachycardia—Epirubicin—pancreatic cancer	5.11e-05	0.000286	CcSEcCtD
Propafenone—Skin disorder—Epirubicin—pancreatic cancer	5.09e-05	0.000284	CcSEcCtD
Propafenone—Hyperhidrosis—Epirubicin—pancreatic cancer	5.06e-05	0.000283	CcSEcCtD
Propafenone—Chest pain—Doxorubicin—pancreatic cancer	5.05e-05	0.000283	CcSEcCtD
Propafenone—Myalgia—Doxorubicin—pancreatic cancer	5.05e-05	0.000283	CcSEcCtD
Propafenone—Anxiety—Doxorubicin—pancreatic cancer	5.04e-05	0.000282	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	5.02e-05	0.000281	CcSEcCtD
Propafenone—Discomfort—Doxorubicin—pancreatic cancer	4.99e-05	0.000279	CcSEcCtD
Propafenone—Anorexia—Epirubicin—pancreatic cancer	4.99e-05	0.000279	CcSEcCtD
Propafenone—Dry mouth—Doxorubicin—pancreatic cancer	4.94e-05	0.000276	CcSEcCtD
Propafenone—Vomiting—Docetaxel—pancreatic cancer	4.94e-05	0.000276	CcSEcCtD
Propafenone—Rash—Docetaxel—pancreatic cancer	4.89e-05	0.000274	CcSEcCtD
Propafenone—Hypotension—Epirubicin—pancreatic cancer	4.89e-05	0.000274	CcSEcCtD
Propafenone—Dermatitis—Docetaxel—pancreatic cancer	4.89e-05	0.000273	CcSEcCtD
Propafenone—Confusional state—Doxorubicin—pancreatic cancer	4.88e-05	0.000273	CcSEcCtD
Propafenone—Headache—Docetaxel—pancreatic cancer	4.86e-05	0.000272	CcSEcCtD
Propafenone—Oedema—Doxorubicin—pancreatic cancer	4.84e-05	0.000271	CcSEcCtD
Propafenone—Infection—Doxorubicin—pancreatic cancer	4.81e-05	0.000269	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	4.77e-05	0.000267	CcSEcCtD
Propafenone—Shock—Doxorubicin—pancreatic cancer	4.77e-05	0.000267	CcSEcCtD
Propafenone—Nervous system disorder—Doxorubicin—pancreatic cancer	4.75e-05	0.000266	CcSEcCtD
Propafenone—Thrombocytopenia—Doxorubicin—pancreatic cancer	4.74e-05	0.000265	CcSEcCtD
Propafenone—Insomnia—Epirubicin—pancreatic cancer	4.74e-05	0.000265	CcSEcCtD
Propafenone—Tachycardia—Doxorubicin—pancreatic cancer	4.73e-05	0.000264	CcSEcCtD
Propafenone—Skin disorder—Doxorubicin—pancreatic cancer	4.71e-05	0.000263	CcSEcCtD
Propafenone—Paraesthesia—Epirubicin—pancreatic cancer	4.7e-05	0.000263	CcSEcCtD
Propafenone—Hyperhidrosis—Doxorubicin—pancreatic cancer	4.68e-05	0.000262	CcSEcCtD
Propafenone—Dyspnoea—Epirubicin—pancreatic cancer	4.67e-05	0.000261	CcSEcCtD
Propafenone—Somnolence—Epirubicin—pancreatic cancer	4.65e-05	0.00026	CcSEcCtD
Propafenone—Anorexia—Doxorubicin—pancreatic cancer	4.62e-05	0.000258	CcSEcCtD
Propafenone—Nausea—Docetaxel—pancreatic cancer	4.61e-05	0.000258	CcSEcCtD
Propafenone—Dyspepsia—Epirubicin—pancreatic cancer	4.61e-05	0.000258	CcSEcCtD
Propafenone—Decreased appetite—Epirubicin—pancreatic cancer	4.55e-05	0.000255	CcSEcCtD
Propafenone—Hypotension—Doxorubicin—pancreatic cancer	4.53e-05	0.000253	CcSEcCtD
Propafenone—Gastrointestinal disorder—Epirubicin—pancreatic cancer	4.52e-05	0.000253	CcSEcCtD
Propafenone—Fatigue—Epirubicin—pancreatic cancer	4.51e-05	0.000252	CcSEcCtD
Propafenone—Pain—Epirubicin—pancreatic cancer	4.48e-05	0.00025	CcSEcCtD
Propafenone—Constipation—Epirubicin—pancreatic cancer	4.48e-05	0.00025	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	4.41e-05	0.000247	CcSEcCtD
Propafenone—Insomnia—Doxorubicin—pancreatic cancer	4.38e-05	0.000245	CcSEcCtD
Propafenone—Paraesthesia—Doxorubicin—pancreatic cancer	4.35e-05	0.000243	CcSEcCtD
Propafenone—Dyspnoea—Doxorubicin—pancreatic cancer	4.32e-05	0.000242	CcSEcCtD
Propafenone—Feeling abnormal—Epirubicin—pancreatic cancer	4.31e-05	0.000241	CcSEcCtD
Propafenone—Somnolence—Doxorubicin—pancreatic cancer	4.31e-05	0.000241	CcSEcCtD
Propafenone—Gastrointestinal pain—Epirubicin—pancreatic cancer	4.28e-05	0.000239	CcSEcCtD
Propafenone—Dyspepsia—Doxorubicin—pancreatic cancer	4.26e-05	0.000239	CcSEcCtD
Propafenone—Decreased appetite—Doxorubicin—pancreatic cancer	4.21e-05	0.000236	CcSEcCtD
Propafenone—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	4.18e-05	0.000234	CcSEcCtD
Propafenone—Fatigue—Doxorubicin—pancreatic cancer	4.18e-05	0.000234	CcSEcCtD
Propafenone—Urticaria—Epirubicin—pancreatic cancer	4.16e-05	0.000233	CcSEcCtD
Propafenone—Constipation—Doxorubicin—pancreatic cancer	4.14e-05	0.000232	CcSEcCtD
Propafenone—Pain—Doxorubicin—pancreatic cancer	4.14e-05	0.000232	CcSEcCtD
Propafenone—Body temperature increased—Epirubicin—pancreatic cancer	4.14e-05	0.000231	CcSEcCtD
Propafenone—Abdominal pain—Epirubicin—pancreatic cancer	4.14e-05	0.000231	CcSEcCtD
Propafenone—Feeling abnormal—Doxorubicin—pancreatic cancer	3.99e-05	0.000223	CcSEcCtD
Propafenone—Gastrointestinal pain—Doxorubicin—pancreatic cancer	3.96e-05	0.000222	CcSEcCtD
Propafenone—Hypersensitivity—Epirubicin—pancreatic cancer	3.86e-05	0.000216	CcSEcCtD
Propafenone—Urticaria—Doxorubicin—pancreatic cancer	3.85e-05	0.000215	CcSEcCtD
Propafenone—Abdominal pain—Doxorubicin—pancreatic cancer	3.83e-05	0.000214	CcSEcCtD
Propafenone—Body temperature increased—Doxorubicin—pancreatic cancer	3.83e-05	0.000214	CcSEcCtD
Propafenone—Asthenia—Epirubicin—pancreatic cancer	3.76e-05	0.00021	CcSEcCtD
Propafenone—Pruritus—Epirubicin—pancreatic cancer	3.7e-05	0.000207	CcSEcCtD
Propafenone—Diarrhoea—Epirubicin—pancreatic cancer	3.58e-05	0.0002	CcSEcCtD
Propafenone—Hypersensitivity—Doxorubicin—pancreatic cancer	3.57e-05	0.0002	CcSEcCtD
Propafenone—Asthenia—Doxorubicin—pancreatic cancer	3.48e-05	0.000194	CcSEcCtD
Propafenone—Dizziness—Epirubicin—pancreatic cancer	3.46e-05	0.000194	CcSEcCtD
Propafenone—Pruritus—Doxorubicin—pancreatic cancer	3.43e-05	0.000192	CcSEcCtD
Propafenone—Vomiting—Epirubicin—pancreatic cancer	3.33e-05	0.000186	CcSEcCtD
Propafenone—Diarrhoea—Doxorubicin—pancreatic cancer	3.31e-05	0.000185	CcSEcCtD
Propafenone—Rash—Epirubicin—pancreatic cancer	3.3e-05	0.000185	CcSEcCtD
Propafenone—Dermatitis—Epirubicin—pancreatic cancer	3.3e-05	0.000184	CcSEcCtD
Propafenone—Headache—Epirubicin—pancreatic cancer	3.28e-05	0.000183	CcSEcCtD
Propafenone—Dizziness—Doxorubicin—pancreatic cancer	3.2e-05	0.000179	CcSEcCtD
Propafenone—Nausea—Epirubicin—pancreatic cancer	3.11e-05	0.000174	CcSEcCtD
Propafenone—Vomiting—Doxorubicin—pancreatic cancer	3.08e-05	0.000172	CcSEcCtD
Propafenone—Rash—Doxorubicin—pancreatic cancer	3.05e-05	0.000171	CcSEcCtD
Propafenone—Dermatitis—Doxorubicin—pancreatic cancer	3.05e-05	0.000171	CcSEcCtD
Propafenone—Headache—Doxorubicin—pancreatic cancer	3.03e-05	0.00017	CcSEcCtD
Propafenone—Nausea—Doxorubicin—pancreatic cancer	2.88e-05	0.000161	CcSEcCtD
